Medicine and Dentistry
Patient
100%
Therapeutic Procedure
48%
Patient with Inflammatory Bowel Disease
22%
Spontaneous Remission
21%
Patient with Crohn's Disease
16%
Cohort Analysis
14%
Hazard Ratio
14%
Colectomy
14%
Disease
13%
Cohort Effect
13%
Prospective Cohort Study
13%
TNF Inhibitor
13%
Inflammatory Bowel Disease
13%
Follow up
13%
Drug
12%
Quality of Life
11%
Patient with Ulcerative Colitis
10%
Surgery
10%
Cytokine
8%
Combination Therapy
8%
Anti-Inflammatory Drug
8%
Age
7%
Proteinase Inhibitor
6%
Pooled Analysis
6%
Macrophage
6%
Older Adult
6%
Primary Sclerosing Cholangitis
6%
Carbohydrate Intake
6%
Granulocyte
6%
Randomized Controlled Trial
6%
Linoleic Acid
6%
Experience
6%
Portal Vein Thrombosis
6%
T-Helper Cell
6%
Health Care Cost
6%
Cystatin C
6%
Polyunsaturated Fatty Acid
6%
Frailty
6%
Biosimilar
6%
Cataract
6%
Infection
6%
Hospital
5%
Medical Record
5%
Person
5%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
37%
Inflammatory Bowel Disease
37%
Cohort Study
28%
Remission
26%
Atorvastatin
18%
Inflammation
18%
Tumor Necrosis Factor
15%
Anti-Inflammatory Drug
15%
Ulcerative Colitis
13%
Infection
13%
Tumor Necrosis Factor Inhibitor
13%
Antiinflammatory Activity
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Steroids
7%
Adalimumab
7%
Endotoxin
6%
Biological Product
6%
Oxidized Low Density Lipoprotein
6%
Immunosuppressive Agent
6%
Observational Study
6%
Vein Thrombosis
6%
Cataract
6%
Incidence
6%
Calgranulin
5%
Immunology and Microbiology
Monocyte
64%
Macrophage
20%
Inflammation
15%
Tumor Necrosis Factor
15%
CD16
14%
Inflammatory Disorder
6%
Density
6%
Alpha 1-Antitrypsin
6%
Immunosuppressive Drug
6%
Pulmonary Inflammation
6%
Golimumab
6%
Blood Plasma
6%
Mucosa
6%
Death Receptor
6%
Inflammatory Bowel Disease
6%
